MRK241004C110000
- 0.01
- -0.64-98.46%
Merck & Co Newsroom
Weekend reading | merck's 'harem battle'
为了让K药价值持续放大，默沙东开启了一场全球ADC寻觅之旅。
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
EU Regulators Reviewing Safety of Finasteride, Dutasteride
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Should Weakness in Merck & Co., Inc.'s (NYSE:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Express News | EMA: Suicidal Ideation Has Also Recently Been Added as a Possible Side Effect of Unknown Frequency in Product Information for Propecia and Proscar
Merck & Co Options Spot-On: On October 3rd, 100.96K Contracts Were Traded, With 389.56K Open Interest
On October 3rd ET, $Merck & Co(MRK.US)$ had active options trading, with a total trading volume of 100.96K options for the day, of which put options accounted for 49.24% of the total transactions,
Demystifying Merck & Co: Insights From 8 Analyst Reviews
Wells Fargo's 'Core' Stocks: GOOGL, HD, KO, and More
CEOs Are on the Hunt for More M&A. Where the Next Deals Are. -- Barrons.com
Dow Falls 290 Points On Losses For Merck, Intel Shares
Amazon.Com Inc., Goldman Sachs Share Losses Contribute To Dow's 150-Point Fall
Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target
Merck & Co Analyst Ratings
Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More
U.S. Tweaks 2025 Medicare Price Negotiation Process
Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
Nike, Coca-Cola Share Losses Lead Dow's 111-Point Drop
The Covid Era Tech Promises To Reinvent Cancer Treatment